Project Grant HT94252411084
Award Date
12/1/24
Completion Date
11/30/27
Dollars Obligated
$532K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48202, USA
Similar Awards
The Defense Health Agency awarded a $523,663 Project Grant to the Henry Ford Health System - doing business as Henry Ford Hospital, a non-profit hospital in Detroit, Michigan. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports research to investigate the NETRIN G1 ligand as a new immunomodulatory target and early biomarker in pancreatic cancer. The project will be conducted from August 1, 2023 to July 31, 2026. Henry Ford Health System has...
The U.S. Defense Health Agency awarded a $292,260 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Henry Ford Health System in Detroit, Michigan. The grant, with a performance period from July 1, 2025 to June 30, 2028, will support research aimed at "Finding the Missing Link Between Pancreatic Neoplasia and Carcinoma." As a non-profit integrated healthcare provider and research organization, the Henry Ford Health System will leverage its...
The federal Project Grant award of $714,934.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) was awarded to the Henry Ford Health System in Detroit, Michigan to conduct research on "Finding the Missing Link Between Pancreatic Neoplasia and Carcinoma." The award has a performance period from July 1, 2025 to June 30, 2028. The Military Medical Research and Development program supports advanced biomedical research aimed at transforming...
The Henry Ford Health System was awarded a $615,782 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 15, 2022 to July 14, 2025 to investigate paracrine pathways contributing to the growth and invasion of neurofibromas and the role of the cellular microenvironment. Through this research, the awardee aims to advance understanding of medical solutions for neurofibromas,...
The Department of Defense's Defense Health Agency awarded a $620,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Henry Ford Health System in Detroit, Michigan. The grant, awarded on September 30, 2025, with a completion date of September 29, 2027, supports the development of plasmacytoid DC exosomes as a new type of cancer vaccine that overcomes CDC1 dependence and tumor immunosuppression. The funding will enable the Henry Ford Health System,...
This $911,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by the Henry Ford Health System in Detroit, Michigan to target mitochondrial metabolism in ovarian cancer. The award, effective April 1, 2024 through March 31, 2028, will support basic, translational, and clinical research aimed at developing new treatments, diagnostic tools, and preventive measures for this area of military medical importance....
Henry Ford Hospital will receive $1.1 million from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct the project "TRIBBLES 2, A NOVEL TARGET FOR THERAPY OF ENZALUTAMIDE-RESISTANT NEUROENDOCRINE PROSTATE CANCER" from September 1, 2022 through August 31, 2025. This project aims to investigate medical solutions for prostate cancer through basic, applied, and advanced biomedical research focused on developing new...
This $2,402,721.00 Project Grant was awarded on April 15, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of a patient monitoring and decision-support platform for precision health, to be delivered by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF). HJF is a non-profit organization that specializes in providing medical research, education, and training services...
This $749,822 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to develop transformative multistaged treatment approaches for composite tissue injuries. The research aims to transform healthcare for military service members, veterans, and the broader public. The award has a performance period from...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,844,306.00 Project Grant to the Regents of the University of Michigan on September 1, 2025. The grant, titled "COTARGETING NSD1/2 PARALOGS IN AR-DRIVEN CASTRATION-RESISTANT PROSTATE CANCER," will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will investigate innovative medical...